The in cis T251I and P587L POLG1 base changes: Description of a new family and literature review

Carmela Scuderi, Eugenia Borgione, Filippa Castello, Mariangela Lo Giudice, Sandro Santa Paola, Mariaconcetta Giambirtone, Francesco Domenico Di Blasi, Maurizio Elia, Carmelo Amato, Santina Città, Catalda Gagliano, Giuliano Barbarino, Girolamo Aurelio Vitello, Sebastiano Antonino Musumeci

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Mutations in the polymerase gamma-1 (POLG1) gene, encoding the catalytic subunit of the mtDNA-specific polymerase-γ, compromise the stability of mitochondrial DNA (mtDNA) and are responsible for numerous clinical presentations as autosomal dominant or recessive progressive external ophthalmoplegia (PEO), sensory ataxia, neuropathy, dysarthria and ophthalmoparesis (SANDO), spinocerebellar ataxia with epilepsy (SCAE) and Alpers syndrome.POLG1 mutations result in extremely heterogeneous phenotypes which often have overlapping clinical findings, making it difficult to categorize patients into syndromes, and genotype-phenotype correlations are still unclear.We describe a new family with a particular spectrum of clinical signs, that carried the c.752C>T mutation in exon 3 (T251I) and the c.1760C>T in exon 10 (P587L) in cis. These mutations were associated in the proband and in her brother with the new probably pathogenic mutation c.347C>A in exon 2 (P116Q).The proband presented a progressive cognitive impairment, mild myopathy, dilated cardiac right atrium and posterior white matter mild signal alteration, while her brother had migraine, mild myopathy, palpebral ptosis and posterior white matter mild signal alteration. Their mother and their sister carried the in cis T251I and the P587L mutations. The first presented neurosensorial hypoacusia, fatigue, heart block and a cerebral arteriovenous malformation nidus, while the latter had borderline intellectual functioning and signs of muscular involvement. Their father, with the P116Q mutation, had diabetes and myopathy.The complexity of the genotype-phenotype correlations associated with POLG1 mutations is reinforced in this work as evidenced by the presence of different clinic features in patients carrying the same mutations.

Original languageEnglish
Pages (from-to)333-339
Number of pages7
JournalNeuromuscular Disorders
Volume25
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Mutation
Muscular Diseases
Siblings
Exons
Genetic Association Studies
Mitochondrial DNA
Diffuse Cerebral Sclerosis of Schilder
Chronic Progressive External Ophthalmoplegia
Intracranial Arteriovenous Malformations
Ophthalmoplegia
Dysarthria
Heart Block
Eyelids
DNA-Directed DNA Polymerase
Ataxia
Heart Atria
Migraine Disorders
Fathers
Fatigue
Catalytic Domain

Keywords

  • Gene mutation
  • Mental retardation
  • Mitochondrial disease
  • Polymerase gamma

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Genetics(clinical)
  • Neurology
  • Medicine(all)

Cite this

The in cis T251I and P587L POLG1 base changes : Description of a new family and literature review. / Scuderi, Carmela; Borgione, Eugenia; Castello, Filippa; Lo Giudice, Mariangela; Santa Paola, Sandro; Giambirtone, Mariaconcetta; Di Blasi, Francesco Domenico; Elia, Maurizio; Amato, Carmelo; Città, Santina; Gagliano, Catalda; Barbarino, Giuliano; Vitello, Girolamo Aurelio; Musumeci, Sebastiano Antonino.

In: Neuromuscular Disorders, Vol. 25, No. 4, 01.04.2015, p. 333-339.

Research output: Contribution to journalArticle

@article{88746ed21bdd452a9dfd1234067dc0ec,
title = "The in cis T251I and P587L POLG1 base changes: Description of a new family and literature review",
abstract = "Mutations in the polymerase gamma-1 (POLG1) gene, encoding the catalytic subunit of the mtDNA-specific polymerase-γ, compromise the stability of mitochondrial DNA (mtDNA) and are responsible for numerous clinical presentations as autosomal dominant or recessive progressive external ophthalmoplegia (PEO), sensory ataxia, neuropathy, dysarthria and ophthalmoparesis (SANDO), spinocerebellar ataxia with epilepsy (SCAE) and Alpers syndrome.POLG1 mutations result in extremely heterogeneous phenotypes which often have overlapping clinical findings, making it difficult to categorize patients into syndromes, and genotype-phenotype correlations are still unclear.We describe a new family with a particular spectrum of clinical signs, that carried the c.752C>T mutation in exon 3 (T251I) and the c.1760C>T in exon 10 (P587L) in cis. These mutations were associated in the proband and in her brother with the new probably pathogenic mutation c.347C>A in exon 2 (P116Q).The proband presented a progressive cognitive impairment, mild myopathy, dilated cardiac right atrium and posterior white matter mild signal alteration, while her brother had migraine, mild myopathy, palpebral ptosis and posterior white matter mild signal alteration. Their mother and their sister carried the in cis T251I and the P587L mutations. The first presented neurosensorial hypoacusia, fatigue, heart block and a cerebral arteriovenous malformation nidus, while the latter had borderline intellectual functioning and signs of muscular involvement. Their father, with the P116Q mutation, had diabetes and myopathy.The complexity of the genotype-phenotype correlations associated with POLG1 mutations is reinforced in this work as evidenced by the presence of different clinic features in patients carrying the same mutations.",
keywords = "Gene mutation, Mental retardation, Mitochondrial disease, Polymerase gamma",
author = "Carmela Scuderi and Eugenia Borgione and Filippa Castello and {Lo Giudice}, Mariangela and {Santa Paola}, Sandro and Mariaconcetta Giambirtone and {Di Blasi}, {Francesco Domenico} and Maurizio Elia and Carmelo Amato and Santina Citt{\`a} and Catalda Gagliano and Giuliano Barbarino and Vitello, {Girolamo Aurelio} and Musumeci, {Sebastiano Antonino}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.nmd.2015.01.004",
language = "English",
volume = "25",
pages = "333--339",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Ltd",
number = "4",

}

TY - JOUR

T1 - The in cis T251I and P587L POLG1 base changes

T2 - Description of a new family and literature review

AU - Scuderi, Carmela

AU - Borgione, Eugenia

AU - Castello, Filippa

AU - Lo Giudice, Mariangela

AU - Santa Paola, Sandro

AU - Giambirtone, Mariaconcetta

AU - Di Blasi, Francesco Domenico

AU - Elia, Maurizio

AU - Amato, Carmelo

AU - Città, Santina

AU - Gagliano, Catalda

AU - Barbarino, Giuliano

AU - Vitello, Girolamo Aurelio

AU - Musumeci, Sebastiano Antonino

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Mutations in the polymerase gamma-1 (POLG1) gene, encoding the catalytic subunit of the mtDNA-specific polymerase-γ, compromise the stability of mitochondrial DNA (mtDNA) and are responsible for numerous clinical presentations as autosomal dominant or recessive progressive external ophthalmoplegia (PEO), sensory ataxia, neuropathy, dysarthria and ophthalmoparesis (SANDO), spinocerebellar ataxia with epilepsy (SCAE) and Alpers syndrome.POLG1 mutations result in extremely heterogeneous phenotypes which often have overlapping clinical findings, making it difficult to categorize patients into syndromes, and genotype-phenotype correlations are still unclear.We describe a new family with a particular spectrum of clinical signs, that carried the c.752C>T mutation in exon 3 (T251I) and the c.1760C>T in exon 10 (P587L) in cis. These mutations were associated in the proband and in her brother with the new probably pathogenic mutation c.347C>A in exon 2 (P116Q).The proband presented a progressive cognitive impairment, mild myopathy, dilated cardiac right atrium and posterior white matter mild signal alteration, while her brother had migraine, mild myopathy, palpebral ptosis and posterior white matter mild signal alteration. Their mother and their sister carried the in cis T251I and the P587L mutations. The first presented neurosensorial hypoacusia, fatigue, heart block and a cerebral arteriovenous malformation nidus, while the latter had borderline intellectual functioning and signs of muscular involvement. Their father, with the P116Q mutation, had diabetes and myopathy.The complexity of the genotype-phenotype correlations associated with POLG1 mutations is reinforced in this work as evidenced by the presence of different clinic features in patients carrying the same mutations.

AB - Mutations in the polymerase gamma-1 (POLG1) gene, encoding the catalytic subunit of the mtDNA-specific polymerase-γ, compromise the stability of mitochondrial DNA (mtDNA) and are responsible for numerous clinical presentations as autosomal dominant or recessive progressive external ophthalmoplegia (PEO), sensory ataxia, neuropathy, dysarthria and ophthalmoparesis (SANDO), spinocerebellar ataxia with epilepsy (SCAE) and Alpers syndrome.POLG1 mutations result in extremely heterogeneous phenotypes which often have overlapping clinical findings, making it difficult to categorize patients into syndromes, and genotype-phenotype correlations are still unclear.We describe a new family with a particular spectrum of clinical signs, that carried the c.752C>T mutation in exon 3 (T251I) and the c.1760C>T in exon 10 (P587L) in cis. These mutations were associated in the proband and in her brother with the new probably pathogenic mutation c.347C>A in exon 2 (P116Q).The proband presented a progressive cognitive impairment, mild myopathy, dilated cardiac right atrium and posterior white matter mild signal alteration, while her brother had migraine, mild myopathy, palpebral ptosis and posterior white matter mild signal alteration. Their mother and their sister carried the in cis T251I and the P587L mutations. The first presented neurosensorial hypoacusia, fatigue, heart block and a cerebral arteriovenous malformation nidus, while the latter had borderline intellectual functioning and signs of muscular involvement. Their father, with the P116Q mutation, had diabetes and myopathy.The complexity of the genotype-phenotype correlations associated with POLG1 mutations is reinforced in this work as evidenced by the presence of different clinic features in patients carrying the same mutations.

KW - Gene mutation

KW - Mental retardation

KW - Mitochondrial disease

KW - Polymerase gamma

UR - http://www.scopus.com/inward/record.url?scp=84925253004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925253004&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2015.01.004

DO - 10.1016/j.nmd.2015.01.004

M3 - Article

C2 - 25660390

AN - SCOPUS:84925253004

VL - 25

SP - 333

EP - 339

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 4

ER -